Collet, Marie O. http://orcid.org/0000-0002-8387-3960
,
Caballero, Jesús
Sonneville, Romain
Bozza, Fernando A.
Nydahl, Peter
Schandl, Anna
Wøien, Hilden
Citerio, Giuseppe
van den Boogaard, Mark
Hästbacka, Johanna
Haenggi, Matthias
Colpaert, Kirsten
Rose, Louise
Barbateskovic, Marija
Lange, Theis
Jensen, Aksel
Krog, Martin B.
Egerod, Ingrid
Nibro, Helle L.
Wetterslev, Jørn
Perner, Anders
Funding for this research was provided by:
Innovation Foundation Denmark
Article History
Received: 6 February 2018
Accepted: 30 April 2018
First Online: 16 May 2018
Compliance with ethical standards
:
: The ICU at Rigshospitalet has received support for research from Fresenius Kabi, CSL Behring and Ferring Pharmaceuticals. The ICU at Bern University Hospital has received support from Orion Corporation, Abbott Nutrition International, B. Braun Medical AG, CSEM SA, Edwards Lifesciences Services GmbH/SA, Kenta Biotech Ltd, Maquet Critical Care AB, Omnicare Clinical research AG and Nestlé. Same ICU department received educational grants from Fresenius Kabi, GSK, MSD, Lilly, Baxter, Astellas, AstraZeneca, B. Braun Medical AG, CSL Behring, Maquet, Novartis, Covidien, Nycomed, Pierre Fabre Pharma (Robe Pharma), Pfizer, and Orion Pharma. Author Jesus Caballero has received funds from Astellas, Medtronic, Sedana Medical, Orion Pharma, Pfizer and Brinda Healthcare.
Free to read: This content has been made available to all.